Fink JK. Hereditary spastic paraplegia: clinical principles and genetic advances. Semin Neurol. 2014;34:293–305.
Article
PubMed
Google Scholar
Durr A, Brice A, Serdaru M, et al. The phenotype of “pure” autosomal dominant spastic paraplegia. Neurology. 1994;44:1274–7.
Article
CAS
PubMed
Google Scholar
Blackstone C. Cellular pathways of hereditary spastic paraplegia. Annu Rev Neurosci. 2012;35:25–47.
Article
CAS
PubMed
Google Scholar
Zhu PP, Denton KR, Pierson TM, Li XJ, Blackstone C. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A. Hum Mol Genet. 2014;23:5638–48.
Article
PubMed
Google Scholar
Timmerman V, Clowes VE, Reid E. Overlapping molecular pathological themes link Charcot-Marie-Tooth neuropathies and hereditary spastic paraplegias. Exp Neurol. 2013;246:14–25.
Article
CAS
PubMed
Google Scholar
Neumann S, Schmid SL. Dual role of BAR domain-containing proteins in regulating vesicle release catalyzed by the GTPase, dynamin-2. J Biol Chem. 2013;288:25119–28.
Article
PubMed Central
CAS
PubMed
Google Scholar
Raimondi A, Ferguson SM, Lou X, Armbruster M, Paradise S, Giovedi S, et al. Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron. 2011;70:1100–14.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ferguson SM, De Camilli P. Dynamin, a membrane-remodelling GTPase. Nat Rev Mol Cell Biol. 2012;13:75–88.
PubMed Central
CAS
PubMed
Google Scholar
Praefcke GJ, McMahon HT. The dynamin superfamily: universal membrane abulation and fission molecules? Nature Rev Mol Cell Biol. 2004;5:133–47.
Article
CAS
Google Scholar
Muhlberg AB, Warnock DE, Schmid SL. Domain structure and intramolecular regulation of dynamin GTPase. EMBO J. 1997;16:6676–83.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kenniston JA, Lemmon MA. Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients. EMBO J. 2010;29:3054–67.
Article
PubMed Central
CAS
PubMed
Google Scholar
Züchner S, Noureddine M, Kennerson M, Verhoeven K, Claeys K, et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease. Nat Genet. 2005;37:289–94.
Article
PubMed
Google Scholar
Kennerson ML, Zhu D, Gardner RJ, Storey E, Merory J, Robertson SP, et al. Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. Am J Hum Genet. 2001;69:883–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bitoun M, Maugenre S, Jeannet PY, Lacene E, Ferrer X, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet. 2005;37:1207–9.
Article
CAS
PubMed
Google Scholar
Goldfarb LG, Gajdusek DC. Viliuisk Encephalomyelitis in the Yakut people of Siberia. Brain. 1992;115:961–78.
Article
PubMed
Google Scholar
Adams DR, Sincan M, Fuentes Fajardo K, Mullikin JC, Pierson TM, Toro C, et al. Analysis of DNA sequence variants detected by high-throughput sequencing. Hum Mutat. 2012;33:599–608.
Article
PubMed Central
CAS
PubMed
Google Scholar
Taylor MJ, Perrais D, Merrifield CJ. A high precision survey of the molecular dynamics of mammalian clathrin-mediated endocytosis. PloS Biol. 2011;9(3), e1000604.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sambuughin N, Swietnicki W, Techtmann S, Matrosova V, Wallace T, Goldfarb L, et al. KBTBD13 interacts with Cullin 3 to form functional ubiquitin ligase. Biochem Biophys Res Comm. 2012;421:743–9.
Article
CAS
PubMed
Google Scholar
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: Protein structure and function prediction. Nature Methods. 2015;12:7–8.
Article
PubMed Central
CAS
PubMed
Google Scholar
Roy A, Kucukural A, Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols. 2010;5:725–38.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhang Y. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics. 2008;9:40.
Article
PubMed Central
PubMed
Google Scholar
Faelber K, Posor Y, Gao S, Held M, Roske Y, Schulze D, et al. Crystal structure of nucleotide-free dynamin. Nature. 2011;477:556–60.
Article
CAS
PubMed
Google Scholar
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–12.
Article
CAS
PubMed
Google Scholar
Sundborger AC, Fang S, Heymann JA, Ray P, Chappie JS, Hinshaw JE. A dynamin mutant defines a superconstricted prefission state. Cell Rep. 2014;8:734–42.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ruano L, Melo C, Silva MC, Coutinho P. The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology. 2014;42:174–83.
Article
PubMed
Google Scholar
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.
Article
CAS
PubMed
Google Scholar
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.
Article
PubMed Central
CAS
PubMed
Google Scholar
Koutspoulos OS, Koch C, Tosch V, Bohm J, North KN, Laporte J. Mild functional differences of dynamin 2 mutations associated to Centronuclaer myopathy and Charcot-Marie-Tooth peripheral neuropathy. PloS One. 2011;6, e27498.
Article
Google Scholar
Chappie JS, Acharya S, Leonard M, Schmid SL, Dyda F. G domain dimerization controls dynamin’s assembly-stimulated GTPase activity. Nature. 2010;465:435–40.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chappie JS, Mears JA, Fang S, Leonard M, Schmid SL, Milligan RA, et al. A pseudoatomic model of the dynamin polymer identifies a hydrolysis-dependent powerstroke. Cell. 2011;147:209–22.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kumar KR, Sue CM, Burke D, Ng K. Peripheral neuropathy in hereditary spastic paraplegia due to spastin (SPG4) mutation–a neurophysiological study using excitability techniques. Clin Neurophysiol. 2012;123:1454–9.
Article
PubMed
Google Scholar
Fabrizi GM, Ferrarini M, Cavallaro T, Cabrini I, Cerini R, Bertolasi L, et al. Two novel mutations in dynamin-2 cause axonal Charcot-Marie-Tooth disease. Neurology. 2007;69:291–5.
Article
CAS
PubMed
Google Scholar
Claeys KG, Züchner S, Kennerson M, Berciano J, Garcia A, Verhoeven K, et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. Brain. 2009;132:1741–52.
Article
PubMed Central
PubMed
Google Scholar
Goizet C, Boukhris A, Mundwiller E, et al. Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat. 2009;30(2):E376–385.
Article
PubMed
Google Scholar
Crimella C, Baschirotto C, Arnoldi A, Tonelli A, Tenderini E, Airoldi G, et al. Mutations in the motor and stalk domains of KIF5A in spastic paraplegia type 10 and in axonal Charcot–Marie–Tooth type 2. Clinical Genetics. 2012;82:157–64.
Article
CAS
PubMed
Google Scholar
Bitoun M, Durieux AC, Prudhon B, Bevilacqua JA, Herledan A, et al. Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis. Hum Mutat. 2009;30:1419–27.
Article
CAS
PubMed
Google Scholar
Schessl J, Medne L, Hu Y, Zou Y, Brown MJ, Huse JT, et al. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement. Neuromuscul Disord. 2007;17:28–32.
Article
PubMed
Google Scholar
Romero NB, Bitoun M. Centronuclear myopathies. Semin Pediatr Neurol. 2011;18:250–6.
Article
PubMed
Google Scholar
Fischer D, Herasse M, Bitoun M, Barragán-Campos HM, Chiras J, Laforêt P, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain. 2006;129:1463–9.
Article
PubMed
Google Scholar
Schmid SL, Frolov VA. Dynamin: functional design of a membrane fission catalyst. Annu Rev Cell Dev Biol. 2011;27:79–105.
Article
CAS
PubMed
Google Scholar
Srinivasan S, Mattila JP, Schmid SL. Intrapolypeptide interactions between the GTPase effector domain (GED) and the GTPase domain form the bundle signaling element in dynamin dimers. Biochemistry. 2014;53:5724–6.
Article
PubMed Central
CAS
PubMed
Google Scholar
Guelly C, Zhu P-P, Leonardis L, Papic L, Zidar J, Schabhuttl M, et al. Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type I. Am J Hum Genet. 2011;88:99–105.
Article
PubMed Central
CAS
PubMed
Google Scholar
Alvarez V, Sánchez-Ferrero E, Beetz C, Díaz M, Alonso B, Corao AI, et al. Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol. 2010;10:89.
PubMed Central
PubMed
Google Scholar